Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator

European Heart Journal
R W Smalling

Abstract

Thrombolytic therapy has been recognized as a significant improvement in the management of acute myocardial infarction. Thrombolytic agents however have been limited by short half-lives that necessitate complex administration protocols and by the potential for bleeding complications. The native t-PA molecule has since been modified in an attempt to achieve improved lytic characteristics with less risk of bleeding. Reteplase is a third-generation recombinant mutant of tissue-type plasminogen activator (t-PA) that is expressed in Escherichia coli cells and consists of the kringle 2 and the protease domains of t-PA. Compared with t-PA, reteplase has a lower fibrin binding, which may translate to improved clot penetration. As well as a longer half-life and a more rapid initiation of thrombolysis. Preclinical pharmacology studies have indicated that reteplase has potent in vivo thrombolytic activity and leads to rapid reperfusion; these findings have been confirmed by promising results obtained in large-scale clinical trials. Other new agents developed by modifying the native t-PA molecule include the n-PA and the TNK mutants of t-PA. These novel, genetically modified thrombolytic agents all lyse clots better than the native t-PA; h...Continue Reading

Citations

Oct 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·E E SánchezJ C Pérez
Aug 25, 2001·Clinical Therapeutics·L Davydov, J W Cheng
Oct 3, 1998·Intensive Care Medicine·N CurzenA Timmis
Nov 12, 2013·Indian Heart Journal·Jamshed DalalK A Sambasivam
Feb 20, 2007·Biochemical and Biophysical Research Communications·Fang WuRongxiu Li
Mar 21, 2001·Biological & Pharmaceutical Bulletin·S AokiY Tanigawara
Feb 16, 2006·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Bjarne Madsen HärdigS Bertil Olsson
Jul 11, 2019·Scientific Reports·Himanshu ShekharChristy K Holland
Aug 8, 2001·Journal of Pharmaceutical and Biomedical Analysis·S AokiK Okumura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.